Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-09-21 5:24 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 4,736,214 23.8% | 1,300,000 (+37.83%) | View |
| 2020-07-20 5:00 pm Purchase | 13D | 89BIO INC ETNB | Longitude Capital Partners III LLC | 2,600,877 15.4% | 109,090 (+4.38%) | View |
| 2020-07-13 4:20 pm Unchanged | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 2,002,221 11.9% | 0 (Unchanged) | View |
| 2020-07-10 4:30 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 3,436,214 20.4% | 275,000 (+8.70%) | View |
| 2020-02-14 09:29 am Purchase | 13G | 89BIO INC ETNB | Nussbaum Ran | 1,134,671 8.2% | 1,134,671 (New Position) | View |
| 2020-01-28 3:15 pm Purchase | 13G | 89BIO INC ETNB | WELLINGTON MANAGEMENT GROUP LLP | 922,999 6.69% | 922,999 (New Position) | View |
| 2019-11-25 4:31 pm Purchase | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 2,002,221 15.4% | 2,002,221 (New Position) | View |
| 2019-11-25 4:05 pm Purchase | 13G | 89BIO INC ETNB | Venrock Healthcare Capital Partners II L.P. | 1,000,000 7.3% | 1,000,000 (New Position) | View |
| 2019-11-21 4:42 pm Purchase | 13D | 89BIO INC ETNB | Longitude Capital Partners III LLC | 2,491,787 19.2% | 2,491,787 (New Position) | View |
| 2019-11-13 5:05 pm Purchase | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 3,161,214 26.2% | 3,161,214 (New Position) | View |